Accessing the Indian vaccine markets might not be for the faint hearted and may appear daunting to pharma companies looking to enter this South Asia giant. In a recent article on the business standard, these barriers have not deterred global majors who are trying to get into the high-growth vaccine market in India through standalone launches and alliances with local partners.
At World Vaccine Congress Asia this year, Durgaprasad Mishra, Head, Marketing & Sales, Zydus Vaxxicare shared with us on some insights on how one might overcome these challenges to gain access to the Indian vaccine markets
His presentation revolved around the major challenges and his insights on what can be done. The challenges are:
- Physician perspective
- Consumer insight
- Government of India perspective
- Drug and formulation regulatory bodies
For more information on World Vaccine Congress Asia and how you can participate, visit: www.terrapinn.com/vaccineasia now